Collaborative Consortia for the Study of HIV-Associated Cancers: U.S. and Low-and Middle-Income Country Partnerships (U54)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to fund research on HIV-associated cancers in low- and middle-income countries (LMICs) through collaborative efforts between investigators in United States (U.S.) and investigators in LMICs. The FOA will also support the enhancement of research capacity of LMIC institutions for research in this area. The FOA solicits applications for Specialized Center Cooperative Agreements (U54) for research on HIV-associated cancers from research institutions in the U.S. and LMICs.  Each application is required to propose between two to three research projects that address high-priority questions relevant to both the LMIC and the NIH HIV/AIDS research agenda.  The proposed projects may range, as appropriate, from basic research to translational efforts as well as population and implementation studies. Clinical trials, however, will not be supported.  In addition, the proposed consortium must include two mandatory cores; an Administrative Core and a Career Enhancement Core.  Additional cores such as Shared Resource cores may be included as appropriate for the needs of the projects.

Applicant organizations may submit only one application in response to this FOA.

Deadlines:

  • Duke Internal Deadline: November 20, 2016
  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): December 20, 2016
  • AIDS Application Due Date(s): December 20, 2016

RFA-CA-16-018 Expiration Date December 21, 2016

Agency Website

Eligibility Requirements

U.S. applicants are encouraged to include LMIC individuals who meet the eligibility requirement as a Multiple PD/PI (see http://grants.nih.gov/grants/multi_pi/ for more information). Applicants are strongly encouraged to take advantage of the multiple PD/PI option so that both U.S. and LMIC investigators share responsibility for the consortium at the leadership level. If the multiple PD/PI option is used, the contact PD/PI should have their primary appointment at the institution submitting the application.

All individuals designated as PDs/PIs must have expertise in HIV/AIDS, oncology or implementation research and the appropriate level of authority and seniority to direct the consortium.

Amount

$3,000,000

Amount Description

Application budgets should be commensurate with the scope of the research activities proposed but must not exceed $600,000 per year in direct costs.

Applicants may request up to five years of support. 

Funding Type

Grant

Eligibility

Faculty

Category

Interdisciplinary
International Opportunities
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

Internal Nomination

Owing to the sponsor's restriction on the number of applications that may be submitted from Duke, anyone wishing to pursue nomination should submit the following materials as one PDF.

* A letter of support from dean or chair - 1 to 1.5 pages
* Project summary - 2 to 4 pages
* CV or Biosketch of project leader

Applicants will need to submit internal materials through My Research Proposal.(Code ILN) https://www.grantinterface.com/Common/LogOn.aspx?eqs=ApVvmgXCk2Uj7AzWyDEJKQ2

Instructions for setting up your account and uploading internal applications can be found here: https://ors.duke.edu/sites/default/files/Applicant Instructions_FINAL.pdf

Internal Deadline

November 20, 2016

External Deadline

December 20, 2016